• L-Phenylephrine: Applied Workflows for α1A Receptor Research

  2026-07-20

  L-Phenylephrine is a highly selective adrenergic α1A receptor agonist that enables reproducible cardiovascular and neural cell assays. This guide covers experimental setups, stepwise workflow enhancements, and troubleshooting strategies to maximize data quality and interpretability. Discover how APExBIO’s high-purity reagent streamlines advanced studies on α1-adrenergic signaling and its physiological implications.

• Phosbind Acrylamide: Precision Phosphate-Binding for SDS-PAG

  2026-07-20

  Phosbind Acrylamide streamlines protein phosphorylation analysis, enabling antibody-free, high-resolution detection of phosphorylation states in complex signaling pathways. Its robust performance in SDS-PAGE empowers researchers to dissect phosphorylation-dependent mobility shifts, as exemplified in studies of AKT-regulated nuclear translocation of FDXR. Discover practical workflow enhancements, troubleshooting strategies, and application insights that set this phosphate-binding reagent apart.

• Pharmacokinetics of Temafloxacin: Insights for Antimicrobial

  2026-07-19

  This review synthesizes the key pharmacokinetic characteristics of temafloxacin, a fluoroquinolone antibiotic, focusing on its high oral bioavailability, extensive tissue distribution, and elimination profile. The findings inform rational dosing regimens and provide a comparative framework for researchers developing or evaluating new antibacterial agents, including macrolides such as Gamithromycin.

• HNF4A-AS1 Loss Drives Sorafenib Resistance via Lipid Metabol

  2026-07-18

  This study reveals that decreased expression of the liver-specific lncRNA HNF4A-AS1 promotes resistance to sorafenib-induced ferroptosis in hepatocellular carcinoma (HCC) by reprogramming lipid metabolism. These findings identify HNF4A-AS1 as a mechanistic link and potential therapeutic target for overcoming drug resistance in HCC.

• Cytochalasin D: Actin Polymerization Inhibitor for Cell Assa

  2026-07-17

  Cytochalasin D enables precise dissection of actin-dependent processes in cell biology and drug delivery research. Learn how this potent actin polymerization inhibitor from APExBIO empowers reproducible workflows, advanced in vitro models, and troubleshooting strategies for both cancer and ocular nanoparticle uptake studies.

• RESTRICT-seq Reveals Epigenetic Dependencies in SCC Resistan

  2026-07-17

  The reference study introduces RESTRICT-seq, a time-gated CRISPR screening strategy that enables precise identification of epigenetic regulators underlying squamous cell carcinoma (SCC) resistance. This approach uncovers novel dependencies, including KAT6A/B, advancing our understanding of epigenetic drug targets and informing future research on senescence induction and cell cycle control.

• 3D Organoid-Fibroblast Co-culture Sheds Light on PDAC Chemor

  2026-07-16

  Schuth et al. introduce a patient-specific, three-dimensional organoid-fibroblast co-culture model for pancreatic ductal adenocarcinoma (PDAC), enabling nuanced investigation of stroma-mediated chemoresistance. Their work uncovers key molecular interactions—especially CAF-driven EMT induction—that inform next-generation drug response assays and translational research.

• Cytoskeleton-Dependent Autophagy Under Mechanical Stress: Ke

  2026-07-16

  Liu et al. (2024) provide the first direct evidence that the cytoskeleton, particularly microfilaments, is indispensable for mechanical stress-induced autophagy in human cells. These findings clarify how cells convert external mechanical cues into autophagic responses, informing future design of mechanotransduction-targeted assays and interventions.

• nor-NOHA Acetate: Precision Modulation of Arginase in Immuno

  2026-07-15

  Explore how nor-NOHA acetate acts as a potent, reversible arginase inhibitor, enabling precise control of arginine metabolism for cancer and immunometabolic research. This article uniquely dissects its mechanistic utility, bridging emerging insights from CD36-driven immune escape to protocol-level decisions.

• Chlorin e6 (Ce6) in Photodynamic Therapy: Reliable Lab Solut

  2026-07-15

  This article provides a scenario-driven roadmap for biomedical researchers seeking validated, reproducible results with Chlorin e6 (Ce6) in photodynamic therapy workflows. Drawing on SKU B8314’s QC standards and recent mechanistic literature, we address real-world protocol, data interpretation, and sourcing challenges to help labs achieve sensitive and robust cell viability or anticancer outcomes.

• HyperScribe All in One mRNA Synthesis Kit: Applied Use Cases

  2026-07-14

  The HyperScribe All in One mRNA Synthesis Kit streamlines ARCA-capped, polyadenylated mRNA production for translational and vaccine research. Its integrated workflow boosts yield, reproducibility, and translation efficiency—ideal for advanced applications like neoantigen vaccine development and RNAi experiments.

• Belinostat (PXD101): Optimizing HDAC Inhibition in Cancer Mo

  2026-07-14

  Belinostat (PXD101) delivers potent, pan-HDAC inhibition for translational cancer research, enabling precise control over chromatin acetylation and cell cycle dynamics. This guide details actionable protocols, troubleshooting strategies, and workflow enhancements for maximizing the impact of Belinostat in bladder and prostate cancer studies.

• Sulfaphenazole Restores Endothelial Function in Diabetic Mic

  2026-07-13

  This study demonstrates that inhibiting cytochrome P450 2C enzymes with Sulfaphenazole reverses endothelial dysfunction in diabetic mice by reducing oxidative stress and increasing nitric oxide availability. The findings highlight CYP2C9 inhibition as a mechanistically targeted strategy for vascular research in diabetes.

• InstaBlue Protein Stain Solution: Precision and Integrity in

  2026-07-13

  Explore how InstaBlue Protein Stain Solution empowers rapid, high-integrity protein detection in polyacrylamide gels. This in-depth analysis goes beyond speed, revealing how preserving protein integrity and mass spectrometry compatibility are redefining biomedical research workflows.

• Copper-Catalyzed Synthesis of Thioazafluoranthenes and Photo

  2026-07-12

  This study introduces a mild, copper-catalyzed tandem radical cyclization strategy for synthesizing sulfur/nitrogen-doped fluoranthenes. The method delivers new fluorophores with tunable optoelectronic properties, expanding the synthetic and functional repertoire of benzosultam frameworks for chemical and materials research.

7351 records 8/491 page Previous Next First page 上5页 678910 下5页 Last page